非侵襲的出生前検査の世界市場レポート 2025年

非侵襲的出生前検査市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は14.9％で、109億5,000万米ドルに成長します。予測期間の成長は、検査提供の拡大、アクセスの拡大、妊産婦年齢の上昇、胎児異常検出、遠隔医療、デジタルヘルスに起因します。予測期間の主な動向には、検査パネルの拡大、niptの広範な採用、技術の進歩、非侵襲的胎児異数性診断（nifad）などがあります。

ダウン症の罹患率の高さは、非侵襲的出生前検査（NIPT）市場の成長を推進する重要な要因であり、特に母体の高齢化の傾向が強まっていることから、胎児の健康に対する懸念が高まっています。ダウン症は、細胞分裂のエラーに起因する染色体疾患であり、21番染色体が余分に存在し、胎児の認知および身体発達に影響を与える可能性があります。NIPTスクリーニング検査は、安全で非侵襲的なダウン症の検出手段を提供し、母体や胎児に害を及ぼすことはなく、流産のリスクもありません。これらの検査により、ダウン症の99％以上を発見することができます。米国では、全米ダウン症協会と疾病管理予防センターは、700人に1人の割合でダウン症児が生まれ、ダウン症児の80％は高齢の母親から生まれると報告しています。母親の高年齢化に伴うリスクの増加が、NIPT市場成長の原動力となっています。

母親の高年齢化の動向は、非侵襲的出生前検査（NIPT）市場の成長を牽引すると予想されます。教育の追求、キャリアアップ、経済的安定、個人の選択、結婚の遅れ、避妊法の改善、社会の変化などの要因が、女性が家族計画についてより多くの情報を得た上で決定することに寄与しています。女性が出産を遅らせるにつれ、染色体異常のリスクが高まるため、妊娠の健康状態をモニターするためにNIPTを選択する妊婦が増えています。例えば、2023年6月に発表された米疾病対策予防センターの報告書では、35歳から39歳の女性の暫定出生率が2％上昇し、2021年の女性1,000人当たりの出生数53.7人から2022年には54.9人になることが強調されています。同様に、30代後半の女性の出生数も2021年から2022年にかけて2％増加しました。40～44歳の年齢層では、暫定出生率が4％上昇し、女性1,000人当たりの出生数は2021年の12人から2022年には12.5人に達しました。この年齢層の出生率は1985年（3.8）以来、ほぼ継続的な伸びを示しています。さらに、この年齢層の出生数は2021年から2022年にかけて6％増加しました。45～49歳女性（50歳以上を含む）の暫定出生率も、2021年の0.9から2022年には女性1,000人当たり1.1に上昇し、2015年以来初めての変化を示しました。このグループの出産数は2021年から2022年にかけて12%急増しました。妊産婦の年齢が上昇を続ける中、非侵襲的出生前検査の需要も予測期間中にそれに応じて伸びることが予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界非侵襲的出生前検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の非侵襲的出生前検査市場：成長率分析
• 世界の非侵襲的出生前検査市場の実績：規模と成長, 2019-2024
• 世界の非侵襲的出生前検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界非侵襲的出生前検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の非侵襲的出生前検査市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 消耗品
• 機器
• 世界の非侵襲的出生前検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• トリソミー
• 微小欠失
• 遺伝学
• Rh因子
• 世界の非侵襲的出生前検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断ラボ
• 世界の非侵襲的出生前検査市場消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アッセイキット
• 試薬
• 使い捨て
• 世界の非侵襲的出生前検査市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 次世代シーケンサー（NGS）
• ポリメラーゼ連鎖反応（PCR）システム
• 超音波装置
• その他（マイクロアレイおよび質量分析計）

第7章 地域別・国別分析

• 世界の非侵襲的出生前検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の非侵襲的出生前検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 非侵襲的出生前検査市場：競合情勢
• 非侵襲的出生前検査市場：企業プロファイル
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • Natera Inc. Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Quest Diagnostics Inc.
• Agilent Technologies Inc.
• BGI Diagnosis Co Ltd.
• Berry Genomics Co
• LifeCodexx AG
• Myriad Genetics Inc.
• NIPD Genetics Co Ltd.
• Sequenom Inc.
• Annoroad Gene Technology Co Ltd.
• Centogene AG
• Counsyl Inc.
• EUROFINS Genoma Group
• Eurofins Scientific SE
• Next Biosciences
• Premaitha Health Plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 非侵襲的出生前検査市場2029：新たな機会を提供する国
• 非侵襲的出生前検査市場2029：新たな機会を提供するセグメント
• 非侵襲的出生前検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Non-invasive prenatal testing (NIPT) is a procedure where maternal blood is drawn and analyzed to detect potential abnormalities in the developing fetus. Non-invasive prenatal testing kits and equipment serve the purpose of identifying genetic irregularities, primarily chromosome defects, during the first trimester of pregnancy.

The key categories of non-invasive prenatal testing encompass consumables and instruments. Consumables refer to products that are used and depleted during their application. Instruments include NGS systems, PCR instruments, microarrays, ultrasound devices, and other equipment like centrifuges, UV systems, incubators, and microscopes. Various consumables comprise assay kits and reagents, as well as disposables. These applications pertain to the detection of conditions such as trisomy, microdeletion, genetics, and the Rh factor, and are typically employed by hospitals and diagnostic laboratories.

The non-invasive prenatal testing market research report is one of a series of new reports from The Business Research Company that provides non-invasive prenatal testing market statistics, including non-invasive prenatal testing industry global market size, regional shares, competitors with a non-invasive prenatal testing market share, detailed non-invasive prenatal testing market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive prenatal testing industry. This non-invasive prenatal testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-invasive prenatal testing market size has grown rapidly in recent years. It will grow from $5.48 billion in 2024 to $6.28 billion in 2025 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to improved accuracy, reduced risk, increased maternal age, growing awareness, clinical guidelines.

The non-invasive prenatal testing market size is expected to see rapid growth in the next few years. It will grow to $10.95 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to expanding test offerings, wider accessibility, rising maternal age, fetal anomaly detection, telemedicine and digital health. Major trends in the forecast period include expanded test panels, wider adoption of nipt, technological advancements, non-invasive fetal aneuploidy diagnosis (nifad).

The high incidence rate of Down syndrome is a significant factor propelling the growth of the non-invasive prenatal testing (NIPT) market, especially with the increasing trend of older maternal age, which raises concerns about fetal well-being. Down syndrome, a chromosomal condition resulting from an error in cell division, leads to an extra chromosome 21 and can impact the cognitive and physical development of the fetus. NIPT screening tests offer a safe and non-invasive means of detecting Down syndrome, posing no harm to the mother or baby and carrying no risk of miscarriage. These tests can identify over 99% of Down syndrome cases. In the USA, the National Down Syndrome Society and the Centers for Disease Control and Prevention report that 1 in every 700 babies is born with Down syndrome, and 80% of children with Down syndrome are born to older mothers. The increased risk associated with advanced maternal age is a driving force behind the growth of the NIPT market.

The growing trend of increasing maternal age is expected to drive the growth of the non-invasive prenatal testing (NIPT) market. Factors such as pursuing education, career advancement, financial stability, personal choice, delayed marriage, improved contraception, and societal shifts are contributing to women making more informed decisions about family planning. As women delay childbirth, the risk of chromosomal abnormalities increases, leading more expectant mothers to choose NIPT to monitor the health of their pregnancies. For example, a report from the Centers for Disease Control and Prevention published in June 2023 highlighted a 2% increase in the provisional birth rate for women aged 35 to 39, from 53.7 births per 1,000 women in 2021 to 54.9 in 2022. Similarly, the number of births to women in their late 30s rose by 2% from 2021 to 2022. In the 40-44 age group, the provisional birth rate increased by 4%, reaching 12.5 births per 1,000 women in 2022, up from 12.0 in 2021. This age group's birth rate has shown nearly continuous growth since 1985 (3.8). Additionally, the number of births in this age group increased by 6% from 2021 to 2022. The provisional birth rate for women aged 45-49 (including those aged 50 and older) also rose to 1.1 births per 1,000 women in 2022, up from 0.9 in 2021, marking the first change in this rate since 2015. The number of births in this group surged by 12% from 2021 to 2022. As maternal age continues to rise, the demand for non-invasive prenatal testing is expected to grow accordingly in the forecast period.

The integration of next-generation sequencing technology has significantly enhanced the capabilities of researchers, enabling them to conduct a wide range of applications and study biological systems at a higher level. Next-generation sequencing allows for the simultaneous sequencing of thousands to millions of DNA molecules, reducing both time and cost while optimizing results for genome and DNA testing. Major companies like Illumina, Eurofins, Natera, Roche, and Annoroad have adopted this technology for non-invasive prenatal testing. The China Food and Drug Administration (CFDA) has approved the medical instrument product registration for Annoroad's NGS instrument NextSeq 550AR.

The non-invasive prenatal testing market is subject to strict regulation by various international and country-specific agencies. For instance, the US Food and Drug Administration (FDA) issues certifications for Laboratory Developed Tests (LDTs) and Clinical Laboratory Improvement Amendments (CLIA). Manufacturers must obtain a 510(k) premarket notification for in vitro diagnostic tests, with LDTs and CLIA certification based on the number of tests conducted during clinical trials. For instance, for trisomy 21 (Down syndrome), with an incidence rate of 1/1000, at least 100,000 samples would need to be tested to meet the requirements of a 510(k). A 510(k) premarket notification ensures that the new product is as safe and effective as other legally-marketed devices, and manufacturers must register such notifications before commercially marketing new products.

In January 2024, Natera, Inc., a US-based clinical genetic testing company, acquired reproductive health assets from Invitae for $42.5 million. This acquisition allows Natera to strengthen its offerings in non-invasive prenatal and carrier screening, which are key components of reproductive health. Invitae is a US-based biotechnology company that provides non-invasive prenatal testing services.

Major companies operating in the non-invasive prenatal testing market include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health PLC, Ariosa Diagnostics Inc., Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc.

North America was the largest region in the non-invasive prenatal testing market in 2024. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the non-invasive prenatal testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The non-invasive prenatal testing market includes revenue earned by ultrasound detection, fetal cells in maternal blood tests, cell-free DNA in maternal plasma tests, and biochemical screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-invasive Prenatal Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-invasive prenatal testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-invasive prenatal testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non-invasive prenatal testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Consumables; Instruments
• 2) By Application: Trisomy; Microdeletion; Genetics; Rh factor
• 3) By End User: Hospital; Diagnostic Labs
• Subsegment:
• 1) By Consumables: Assay Kits; Reagents; Disposables
• 2) By Instruments: Next-Generation Sequencers (NGS); Polymerase Chain Reaction (PCR) Systems; Ultrasound Devices; Others (Microarrays And Mass Spectrometers)
• Companies Mentioned: F. Hoffmann-La Roche AG; Illumina Inc.; Laboratory Corporation of America Holdings; Natera Inc.; PerkinElmer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Non-invasive Prenatal Testing Market Characteristics

3. Non-invasive Prenatal Testing Market Trends And Strategies

4. Non-invasive Prenatal Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Non-invasive Prenatal Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Non-invasive Prenatal Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Non-invasive Prenatal Testing Market Growth Rate Analysis
• 5.4. Global Non-invasive Prenatal Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Non-invasive Prenatal Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Non-invasive Prenatal Testing Total Addressable Market (TAM)

6. Non-invasive Prenatal Testing Market Segmentation

• 6.1. Global Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Instruments
• 6.2. Global Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Trisomy
• Microdeletion
• Genetics
• Rh factor
• 6.3. Global Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Diagnostic Labs
• 6.4. Global Non-invasive Prenatal Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Assay Kits
• Reagents
• Disposables
• 6.5. Global Non-invasive Prenatal Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencers (NGS)
• Polymerase Chain Reaction (PCR) Systems
• Ultrasound Devices
• Others (Microarrays And Mass Spectrometers)

7. Non-invasive Prenatal Testing Market Regional And Country Analysis

• 7.1. Global Non-invasive Prenatal Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Non-invasive Prenatal Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Non-invasive Prenatal Testing Market

• 8.1. Asia-Pacific Non-invasive Prenatal Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Non-invasive Prenatal Testing Market

• 9.1. China Non-invasive Prenatal Testing Market Overview
• 9.2. China Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Non-invasive Prenatal Testing Market

• 10.1. India Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Non-invasive Prenatal Testing Market

• 11.1. Japan Non-invasive Prenatal Testing Market Overview
• 11.2. Japan Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Non-invasive Prenatal Testing Market

• 12.1. Australia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Non-invasive Prenatal Testing Market

• 13.1. Indonesia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Non-invasive Prenatal Testing Market

• 14.1. South Korea Non-invasive Prenatal Testing Market Overview
• 14.2. South Korea Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Non-invasive Prenatal Testing Market

• 15.1. Western Europe Non-invasive Prenatal Testing Market Overview
• 15.2. Western Europe Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Non-invasive Prenatal Testing Market

• 16.1. UK Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Non-invasive Prenatal Testing Market

• 17.1. Germany Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Non-invasive Prenatal Testing Market

• 18.1. France Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Non-invasive Prenatal Testing Market

• 19.1. Italy Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Non-invasive Prenatal Testing Market

• 20.1. Spain Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Non-invasive Prenatal Testing Market

• 21.1. Eastern Europe Non-invasive Prenatal Testing Market Overview
• 21.2. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Non-invasive Prenatal Testing Market

• 22.1. Russia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Non-invasive Prenatal Testing Market

• 23.1. North America Non-invasive Prenatal Testing Market Overview
• 23.2. North America Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Non-invasive Prenatal Testing Market

• 24.1. USA Non-invasive Prenatal Testing Market Overview
• 24.2. USA Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Non-invasive Prenatal Testing Market

• 25.1. Canada Non-invasive Prenatal Testing Market Overview
• 25.2. Canada Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Non-invasive Prenatal Testing Market

• 26.1. South America Non-invasive Prenatal Testing Market Overview
• 26.2. South America Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Non-invasive Prenatal Testing Market

• 27.1. Brazil Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Non-invasive Prenatal Testing Market

• 28.1. Middle East Non-invasive Prenatal Testing Market Overview
• 28.2. Middle East Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Non-invasive Prenatal Testing Market

• 29.1. Africa Non-invasive Prenatal Testing Market Overview
• 29.2. Africa Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Non-invasive Prenatal Testing Market Competitive Landscape And Company Profiles

• 30.1. Non-invasive Prenatal Testing Market Competitive Landscape
• 30.2. Non-invasive Prenatal Testing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Natera Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Non-invasive Prenatal Testing Market Other Major And Innovative Companies

• 31.1. Quest Diagnostics Inc.
• 31.2. Agilent Technologies Inc.
• 31.3. BGI Diagnosis Co Ltd.
• 31.4. Berry Genomics Co
• 31.5. LifeCodexx AG
• 31.6. Myriad Genetics Inc.
• 31.7. NIPD Genetics Co Ltd.
• 31.8. Sequenom Inc.
• 31.9. Annoroad Gene Technology Co Ltd.
• 31.10. Centogene AG
• 31.11. Counsyl Inc.
• 31.12. EUROFINS Genoma Group
• 31.13. Eurofins Scientific SE
• 31.14. Next Biosciences
• 31.15. Premaitha Health Plc

32. Global Non-invasive Prenatal Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non-invasive Prenatal Testing Market

34. Recent Developments In The Non-invasive Prenatal Testing Market

35. Non-invasive Prenatal Testing Market High Potential Countries, Segments and Strategies

• 35.1 Non-invasive Prenatal Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Non-invasive Prenatal Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Non-invasive Prenatal Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer